Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125226671 | 12522667 | 1 | I | 20160620 | 20160701 | 20160701 | EXP | BR-ELI_LILLY_AND_COMPANY-BR201606007416 | ELI LILLY AND CO | 0.00 | F | Y | 75.00000 | KG | 20160701 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125226671 | 12522667 | 1 | PS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | UNK, QD | U | U | 20563 | INJECTION | QD | ||||||
| 125226671 | 12522667 | 2 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | UNK, UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125226671 | 12522667 | 1 | Diabetes mellitus |
| 125226671 | 12522667 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125226671 | 12522667 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125226671 | 12522667 | Blood glucose abnormal | |
| 125226671 | 12522667 | Cataract | |
| 125226671 | 12522667 | Nosocomial infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125226671 | 12522667 | 1 | 2001 | 0 |